Detalhe da pesquisa
1.
Benefits of early highly effective versus escalation treatment strategies in relapsing multiple sclerosis estimated using a treatment-sequence model.
Mult Scler
; : 13524585241258692, 2024 Jun 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38859625
2.
The relationship of cerebrospinal fluid neurofilament levels with magnetic resonance imaging lesion location and disease activity in multiple sclerosis.
Eur J Neurol
; 29(9): 2754-2760, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35615966
3.
CHIT1 at Diagnosis Reflects Long-Term Multiple Sclerosis Disease Activity.
Ann Neurol
; 87(4): 633-645, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31997416
4.
IFN-γ stimulates CpG-induced IL-10 production in B cells via p38 and JNK signalling pathways.
Eur J Immunol
; 48(9): 1506-1521, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30004580
5.
Multiple sclerosis risk variants alter expression of co-stimulatory genes in B cells.
Brain
; 141(3): 786-796, 2018 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29361022
6.
Presymptomatic MS or radiologically isolated syndrome (RIS) should be actively monitored and treated - NO.
Mult Scler
; 29(7): 795-797, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37212239
7.
Should anti-CD20 be used as an immune reconstitution therapy?
Mult Scler
; 29(2): 308-310, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35822293
8.
Genetic basis for relapse rate in multiple sclerosis: Association with LRP2 genetic variation.
Mult Scler
; 24(13): 1773-1775, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29303040
9.
Regarding: Nicotinic acetylcholine receptors α7 and α9 modify tobacco smoke risk for multiple sclerosis.
Mult Scler
; 27(8): 1311-1312, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33289622
10.
Amyloidoma mimicking multiple sclerosis.
Pract Neurol
; 2021 Feb 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-33627491
11.
Health-economic benefits of anti-CD20 treatments in relapsing multiple sclerosis estimated using a treatment-sequence model.
Mult Scler J Exp Transl Clin
; 9(3): 20552173231189398, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37529628
12.
Benefits of sphingosine-1-phosphate receptor modulators in relapsing MS estimated with a treatment sequence model.
Mult Scler Relat Disord
; 80: 105100, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37944195
13.
Chronic anterior shoulder dislocation: aspects of current management and potential complications.
Acta Orthop Belg
; 78(3): 291-5, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22822566
14.
Derisking CD20-therapies for long-term use.
Mult Scler Relat Disord
; 57: 103418, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34902761
15.
Factors contributing to CSF NfL reduction over time in those starting treatment for multiple sclerosis: An observational study.
Mult Scler Relat Disord
; 57: 103409, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34871856
16.
Quantitative MRI phenotypes capture biological heterogeneity in multiple sclerosis patients.
Sci Rep
; 11(1): 1573, 2021 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33452402
17.
Treatment-Induced BAFF Expression and B Cell Biology in Multiple Sclerosis.
Front Immunol
; 12: 676619, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34122439
18.
CSF neurofilament light chain testing as an aid to determine treatment strategies in MS.
Neurol Neuroimmunol Neuroinflamm
; 7(6)2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32826298
19.
Cerebrovascular events after surgery versus conservative therapy for moyamoya disease: a meta-analysis.
Acta Neurol Belg
; 119(3): 305-313, 2019 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-31215004
20.
Genetic Architecture of Adaptive Immune System Identifies Key Immune Regulators.
Cell Rep
; 25(3): 798-810.e6, 2018 10 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-30332657